We are live on ! Find out more

1,470 hedge funds and large institutions have $103B invested in Merck in 2013 Q3 according to their latest regulatory filings, with 78 funds opening new positions, 567 increasing their positions, 618 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more first-time investments, than exits

New positions opened: 78 | Existing positions closed: 53

36% more call options, than puts

Call options by funds: $1.25B | Put options by funds: $918M

1.32% more ownership

Funds ownership: 76.5%77.82% (+1.3%)

1% more capital invested

Capital invested by funds: $102B → $103B (+$1.08B)

1% more funds holding

Funds holding: 1,4591,470 (+11)

8% less repeat investments, than reductions

Existing positions increased: 567 | Existing positions reduced: 618

3% less funds holding in top 10

Funds holding in top 10: 120117 (-3)

Holders
1,470
Holders Change
+11
Holders Change %
+0.75%
% of All Funds
47.48%
Holding in Top 10
117
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-2.5%
% of All Funds
3.78%
New
78
Increased
567
Reduced
618
Closed
53
Calls
$1.25B
Puts
$918M
Net Calls
+$331M
Net Calls Change
-$115M

MRK Hedge Fund Activity: Q3 2013 in Review

1,470 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2013, worth a combined $103B — up 1.1% from $102B a quarter earlier.

Buyers outnumbered sellers: 78 funds opened new MRK positions and 53 closed out — a net gain of 25 holders — while 567 added to existing stakes and 618 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $192M. The largest seller was Fidelity Investments, cutting an estimated $612M.

  • 1,470 institutional investors held Merck (MRK) as of Q3 2013, up from 1,459 in Q2 2013.
  • Funds reported $103B of Merck stock for Q3 2013, up 1.1% quarter-over-quarter.
  • 78 funds opened new Merck positions in Q3 2013 and 53 closed out, a net change of +25 holders.
  • The largest Merck buyer in Q3 2013 was Eagle Asset Management, an estimated $192M added.
  • The largest Merck seller in Q3 2013 was Fidelity Investments, an estimated $612M sold.

Based on aggregated 13F filings for Q3 2013.